UBTF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.478700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.138000E-01
Normal-vs-Stage2
5.640100E-03
Normal-vs-Stage3
1.355600E-01
Normal-vs-Stage4
5.172200E-01
Stage1-vs-Stage2
5.435200E-01
Stage1-vs-Stage3
3.382000E-01
Stage1-vs-Stage4
3.091400E-01
Stage2-vs-Stage3
5.015000E-01
Stage2-vs-Stage4
8.581700E-02
Stage3-vs-Stage4
2.031800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.033900E-02
Normal-vs-AfricanAmerican
1.826980E-01
Normal-vs-Asian
1.852050E-02
Caucasian-vs-AfricanAmerican
4.272600E-01
Caucasian-vs-Asian
1.228040E-01
AfricanAmerican-vs-Asian
1.032380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.407890E-02
Normal-vs-Female
1.000400E-02
Male-vs-Female
8.871400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.560000E-01
Normal-vs-Age(41-60Yrs)
3.152400E-01
Normal-vs-Age(61-80Yrs)
1.611920E-02
Normal-vs-Age(81-100Yrs)
2.626600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.972800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.626200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.455000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.126100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.100800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.556800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.246270E-02
Normal-vs-Daily Drinker
7.380300E-03
Normal-vs-Weekly Drinker
3.814000E-02
Normal-vs-Occasional Drinker
9.969500E-02
Normal-vs-Social Drinker
3.027000E-01
Non Drinker-vs-Daily Drinker
5.660200E-01
Non Drinker-vs-Weekly Drinker
5.353800E-01
Non Drinker-vs-Occasional Drinker
3.738100E-02
Non Drinker-vs-Social Drinker
1.351630E-01
Daily Drinker-vs-Weekly Drinker
8.563400E-01
Daily Drinker-vs-Occasional Drinker
7.808200E-02
Daily Drinker-vs-Social Drinker
2.372200E-01
Weekly Drinker-vs-Occasional Drinker
2.037200E-01
Weekly Drinker-vs-Social Drinker
4.297400E-01
Occasional Drinker-vs-Social Drinker
5.260000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.758810E-01
Normal-vs-Grade 2
5.698400E-01
Normal-vs-Grade 3
5.509600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.681200E-01
Grade 1-vs-Grade 3
8.021000E-01
Grade 1-vs-Grade 4
1.758810E-01
Grade 2-vs-Grade 3
5.825200E-01
Grade 2-vs-Grade 4
5.698400E-01
Grade 3-vs-Grade 4
5.509600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.612500E-02
Normal-vs-NonDiabetic
4.557400E-03
Diabetic-vs-NonDiabetic
6.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.234800E-01
Normal-vs-NoPancreatitis
7.922500E-03
Pancreatitis-vs-NoPancreatitis
5.089000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.037700E-02
Normal-vs-N1
9.096600E-03
N0-vs-N1
9.674400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.713600E-01
Normal-vs-TP53-NonMutant
8.900500E-02
TP53-Mutant-vs-TP53-NonMutant
5.247400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
